H+H International A/S
Helen Macphee has been a board member at H+H International A/S since September 2015. Prior to that, they were VP Compliance at AstraZeneca from January 2012 to September 2015, where they were originally in charge of compliance throughout EMEA and for the Global Product Strategy Group. In their time at AstraZeneca, Helen also served as Head of Global Commercial Audit from January 2011 to January 2012, and Head of Group Internal Audit: International Sales & Marketing, HR and Corporate Affairs from June 2008 to January 2011. From January 2006 to May 2008, they were CFO of AstraZeneca Netherlands.
Helen Macphee is an ACA and has a Master's Degree in Economics from the University of Bristol. Helen also attended Perse School Cambridge.
This person is not in the org chart
This person is not in any offices
H+H International A/S
H+H International A/S (H+H) is a Denmark-based company engaged in the construction supplies area. The Company specializes in the manufacture and sale of autoclaved aerated concrete (aircrete). The Company's aircrete has various applications, including panels and blocks for constructing interior and exterior walls, reinforced elements for floors, walls and roofs, reinforced lintels and blocks for interiors, as well as for foundations. Its customers are primarily contractors, residential and industrial developers, as well as builder's merchants. The Company operates in a number of European countries, such as Belgium, Denmark, Germany, Finland, the Netherlands, Sweden, the United Kingdom, Poland, Slovakia and the Russian Federation. Furthermore, It is a parent of H+H Deutschland GmbH, H+H Danmark A/S, Stone Kivitalot Oy, H+H Finland Oy, H+H Benelux BV, and H+H Norge AS, among others.